| Literature DB >> 30613843 |
Wiktoria Jedwabny1, Edyta Dyguda-Kazimierowicz2.
Abstract
Halogenated ligands are nowadays commonly designed in order to increase their potency against protein targets. Although novel computational methods of evaluating the affinity of such halogenated inhibitors have emerged, they still lack the sufficient accuracy, which is especially noticeable in the case of empirical scoring functions, being the method of choice in the drug design process. Here, we evaluated a series of halogenated inhibitors of phosphodiesterase type 5 with ab initio methods, revealing the physical nature of ligand binding and determining the components of interaction energy that are essential for proper inhibitor ranking. In particular, a nonempirical scoring model combining long-range contributions to the interaction energy provided a significant correlation with experimental binding potency, outperforming a number of commonly used empirical scoring functions. Considering the low computational cost associated with remarkable predictive abilities of the aforementioned model, it could be used for rapid assessment of the ligand affinity in the process of rational design of novel halogenated compounds.Entities:
Keywords: Inhibitors; Interaction energy; PDE5; Scoring
Mesh:
Substances:
Year: 2019 PMID: 30613843 PMCID: PMC6321839 DOI: 10.1007/s00894-018-3897-z
Source DB: PubMed Journal: J Mol Model ISSN: 0948-5023 Impact factor: 1.810
Fig. 1The structures of PDE5 inhibitors. Binding energy calculations were performed for the part of the structure marked in red
Fig. 2PDE5 binding site representation in complex with the model of 5-I inhibitor
Total PDE5-inhibitor interaction energy at the consecutive levels of theory
| Inhibitor |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 5-I | 6.82 | − 19.6 | − 36.5 | 10.4 | − 5.1 | − 33.4 | − 55.1 |
| 5-Br | 6.38 | − 19.7 | − 36.7 | 11.9 | − 3.2 | − 30.1 | − 52.9 |
| 5-Cl | 6.12 | − 17.0 | − 30.2 | 4.5 | − 7.7 | − 30.1 | − 46.5 |
| 5-H | 5.84 | − 19.4 | − 35.3 | 5.6 | − 7.9 | − 28.7 | − 47.6 |
| 5-F | 5.76 | − 18.1 | − 32.4 | 5.9 | − 6.8 | − 26.7 | − 45.7 |
| R | − 0.45 | − 0.54 | 0.75 | 0.66 | − 0.95 | − 0.93 | |
|
| 70.0 | 70.0 | 40.0 | 30.0 | 100.0 | 90.0 | |
a In units of kcal ⋅ mol− 1
b K values are taken from Ref. [32]
c Correlation coefficient between the energy obtained at a given level of theory and the experimental inhibitory activity
d Percentage of successful predictions [%]
Solvation free energy (ΔG) of PDE5 inhibitors along with the electrostatic (ΔG) and non-electrostatic (ΔG) contributions.
| Inhibitor | Δ | Δ | Δ |
|---|---|---|---|
| 5-I | − 8.6 | − 11.7 | 3.2 |
| 5-Br | − 7.4 | − 10.2 | 2.8 |
| 5-Cl | − 7.2 | − 10.7 | 3.5 |
| 5-H | − 8.3 | − 11.9 | 3.6 |
| 5-F | − 6.9 | − 11.0 | 4.1 |
|
| 0.73 | 0.72 | 0.46 |
a In units of kcal ⋅mol− 1
b Standard deviation calculated for the ΔG energy values; in units of kcal ⋅mol− 1
Fig. 3Contribution of individual amino acid residues or residue pairs to E interaction energy of PDE5 inhibitors
Fig. 4Pearson correlation coefficients obtained for the empirical scoring functions and nonempirical model